Together We Intend to Overcome Barriers to Access Treatment and Secure Supply of Pediatric Antiretroviral Therapy Formulations
Vatican City, Johnson & Johnson announced that Janssen Pharmaceutica NV, part of its Janssen Pharmaceutical Companies, is working with the U.S. President’s Emergency Plan for AIDS Relief (PEPFAR) with the intention of expanding access to lifesaving HIV antiretroviral therapy (ART) for children in the developing world. The initiative seeks to address the fact that only about half of children under age 15 in the developing world are benefiting from ART. This was announced at a conference on pediatric HIV care taking place today in the Vatican City.
Antiretroviral therapy does not affect resting energy expenditure among women with HIV, according to Journal of the Academy of Nutrition and Dietetics report
Philadelphia, PA, April 16, 2013 /3BL Media/ – Studies have shown that about 10 percent of men infected with human immunodeficiency virus (HIV) have an elevated resting energy expenditure (REE). Their bodies use more kilocalories for basic functions including circulation, body temperature, and breathing. Most studies have been conducted in men and those with solely women have had small sample sizes. A team of researchers has sought to rectify this with a matched, prospective, cross-sectional study.